3:2822 Nov 2026
Hacker Newsroom for 22 November: Pancreatic Cancer Trial, Slopstrap Satire, Lead Azide Stockpile
Hacker Newsroom for 22 November recaps major Hacker News stories, moving through pancreatic cancer trial, slopstrap satire, lead azide stockpile. Chapters 00:00:00 — Intro 00:00:16 — Pancreatic Cancer Trial 00:01:19 — Slopstrap Satire 00:02:22 — Lead Azide Stockpile 00:03:18 — Closing 1. Pancreatic Cancer Trial The Guardian’s article reports early results for daraxonrasib, a KRAS inhibitor tested in 61 people with advanced pancreatic cancer. Tumors stopped growing in 90% of patients, and more…













